ClinicalTrials.gg
CompletedNCT06014476Updated Aug 28, 2023

Psychological Symptoms and Burden in Caregivers of Patients With Disorders of Consciousness

An observational study in Psychological Distress, Anxiety Depression and Burden, Caregiver, sponsored by Hangzhou Normal University. Completed at 1 site in China. Open to participants aged 17 Years to 81 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-08-28.

Sponsored by Hangzhou Normal University · Observational

Study type
Observational
Model
Family-based
Time perspective
Cross-sectional
Enrollment
256
Ages
17 Years to 81 Years
Sex
All
01

Study summary

Caregivers of patients with disorders of consciousness are highly prone to developing mental health issues. The aim of this study is to investigate the psychological symptoms and care burden of caregivers of patients with disorders of consciousness (DoC), and to examine which characteristics of patients were burden predictors to caregivers.

Read the detailed description

This is a multi-center cross-sectional study in China, from August 2021 to October 2022. Patients were assessed by Coma Recovery Scale-Revised (CRS-R), and caregivers' anxiety, depression, and burden were assessed by State-Trait Anxiety Inventory Form Y (STAI), Beck Depression Inventory-II (BDI- II), and Zarit Caregiver Burden scale (ZBI). The comparison with patients' age and caregivers' age-matched subjects who were randomly selected and without DoC; intra-group comparison of caregivers for DoC was conducted. Descriptive statistics were used to illustrate the socio-demographics. One-sample t-test, independent sample t-test, one-way ANOVA, Mann-Whitney U test, and Kruskal-Wallis test were executed to detect the difference between groups due to the distribution of each variable.

02

Conditions studied

  • Psychological Distress
  • Anxiety Depression
  • Burden, Caregiver
  • Disorders of Consciousness
03

In context

Caregiver Burden

500 studies on the registry are indexed under Caregiver Burden; 164 are open to participants now.

This study's enrollment of 256 is above the median of 100 across 80 observational studies indexed under Caregiver Burden.

Browse Caregiver Burden studies →

Lead sponsor

Hangzhou Normal University is the lead sponsor of 22 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
17 Years to 81 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Caregivers of patients with DoC and other diseases

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • (1) Family caregivers without neurological, mental health, or learning disability history.

(2) Family caregiver with consciousness and capability of independently completing questionnaires.

Exclusion criteria

Exclusion criteria:

  1. Caregivers unwilling to participate
  2. Not the dominant caregivers
05

Study design

Observational model
Family-based
Time perspective
Cross-sectional
Enrollment
256 participants (actual)
Patient registry
No

Groups and cohorts

  • Experimental Group

    Caregivers of patients with disorders of consciousness, including Coma, Unresponsive Wakefulness Syndrome (UWS), and Minimally Consciousness State (MCS). And caregivers of patients emerge from the minimally conscious state (EMCS)

    Other: questionnaires

  • Control group

    caregivers of patients with other disease

    Other: questionnaires

Interventions

  • Otherquestionnaires

    Sent questionnaires to caregivers and used CRS-R to assess patients with DoC

    Also known as: Coma Recovery Scale-Revised (CRS-R)

06

What researchers measure

Primary outcomes

  1. The prevalence of anxiety in caregivers of patients with disorders of consciousness.

    We use the State-Trait Anxiety Inventory Form Y (STAI-Y) to assess the prevalence and severity degree of anxiety for caregivers of patients with disorders of consciousness (DoC) STAI was a self-rating scale, consisting of 40 items and divided into two subscales: 1) state anxiety (S-AI) scale includes questions 1-20, state anxiety shows the transitory unpleasant. 2) trait anxiety (T-AI) scale includes questions 21-40, trait anxiety tends to the personality trait. The cumulative score values of state anxiety and trait anxiety scales were calculated respectively, the minimum to maximum value was from 20 to 80, the higher scores mean a worse outcome.

    Time frame: Within 1 days

  2. The prevalence and severity degree of depression in caregivers of patients with disorders of consciousness.

    We use the Beck Depression Inventory-II (BDI-II) to assess the prevalence and severity degree of depression for caregivers of patients with disorders of consciousness (DoC) BDI total score: 0-13 as no depression, 14-19 as mild depression, 20-28 as medium depression, and 29-63 as severe depression.

    Time frame: Within 1 days

  3. The prevalence and severity degree of burden in caregivers of patients with disorders of consciousness.

    We use the Zarit Caregiver Burden Scale (ZBI) to assess the prevalence and severity degree of burden for caregivers of patients with disorders of consciousness (DoC) ZBI total score: 0-20 indicates no burden, 21-40 mild burden, 41-60 moderate burden, and 61-88 severe burden.

    Time frame: Within 1 days

  4. The predictors of anxiety in caregivers of patients with disorders of consciousness.

    We choose a series of questionnaires to figure out: what are the characteristics of patients and caregivers were caregivers' anxiety predictors? The questionnaires include social-demographic questionnaires (including personal information of patients and caregivers e.g., age, gender, etiology, diagnosis, and so on, to record their basic information) and the State-Trait Anxiety Inventory Form Y (STAI-Y). We used the Independent-sample T-test, one-way ANOVA, Mann-Whitney U test, Kruskal-Wallis test, and Pearson Correlation to calculate the correlation between the characteristics of patients and caregivers and caregivers' anxiety.

    Time frame: Within 1 days

  5. The predictors of depression in caregivers of patients with disorders of consciousness.

    We choose a series of questionnaires to figure out: (1) What are the characteristics of patients and caregivers were caregivers' depression predictors? The questionnaires include social-demographic questionnaires (including personal information of patients and caregivers e.g., age, gender, etiology, diagnosis, and so on, to record their basic information), and the Beck Depression Inventory-II (BDI-II). We used the Independent-sample T-test, one-way ANOVA, Mann-Whitney U test, Kruskal-Wallis test, and Pearson Correlation to calculate the correlation between the characteristics of patients and caregivers and caregivers' depression.

    Time frame: Within 1 days

  6. The predictors of burden in caregivers of patients with disorders of consciousness.

    We choose a series of questionnaires to figure out: (1) What are the characteristics of patients and caregivers were caregivers' burden predictors? The questionnaires include social-demographic questionnaires (including personal information of patients and caregivers e.g., age, gender, etiology, diagnosis, and so on, to record their basic information), and the Zarit Caregiver Burden Scale (ZBI). We used the Independent-sample T-test, one-way ANOVA, Mann-Whitney U test, Kruskal-Wallis test, and Pearson Correlation to calculate the correlation between the characteristics of patients and caregivers and caregivers' burden.

    Time frame: Within 1 days

Secondary outcomes

  1. The diagnoses of patients with disorders of consciousness (DoC)

    The DoC patients were evaluated 3-5 times Coma Recovery Scale-Revised (CRS-R) within 10 days after questionnaire distribution to determine their current state of consciousness.

    Time frame: Within 10 days

  2. The relationship between patient diagnoses and caregivers' anxiety

    We compare patient diagnoses (assessed by Coma Recovery Scale-Revised (CRS-R) ) and caregivers' anxiety (assessed by the State-Trait Anxiety Inventory Form Y (STAI-Y) ) We used the one-way ANOVA to calculate the relationship between patient diagnoses and caregivers' anxiety.

    Time frame: Within 1 days

  3. The relationship between patient diagnoses and caregivers' depression

    We compare patient diagnoses (assessed by Coma Recovery Scale-Revised (CRS-R) ) and caregivers' depression (assessed by the Beck Depression Inventory-II (BDI-II) ) We used the one-way ANOVA to calculate the relationship between patient diagnoses and caregivers' depression.

    Time frame: Within 1 days

  4. The relationship between patient diagnoses and caregivers' burden

    We compare patient diagnoses (assessed by Coma Recovery Scale-Revised (CRS-R) ) and caregivers' depression (assessed by the Zarit Caregiver Burden Scale (ZBI) ) We used the one-way ANOVA to calculate the relationship between patient diagnoses and caregivers' burden.

    Time frame: Within 1 days

07

Study locations

1 site
  • International Vegetative State and Consciousness Science Institute, Hangzhou Normal University
    Hangzhou, Zhejiang, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Aug 2021 to primary completion in Oct 2022, 14 months.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 15, 2023
First posted
Aug 28, 2023
StartActual
Aug 1, 2021
Primary completionActual
Oct 31, 2022
CompletionActual
Oct 31, 2022
Last update
Aug 28, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 28, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06014476
Lead sponsor
Hangzhou Normal University
Responsible party
Haibo Di (Principal Investigator, Hangzhou Normal University) — Principal investigator
First posted
Aug 28, 2023
Start date
Aug 1, 2021
Primary completion
Oct 31, 2022
Completion
Oct 31, 2022
Last update
Aug 28, 2023

Study contacts

Hao YA Wang
study chair · Hangzhou Normal University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion